Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency

被引:64
作者
Wada, T
Toma, T
Okamoto, H
Kasahara, Y
Koizumi, S
Agematsu, K
Kimura, H
Shimada, A
Hayashi, Y
Kato, M
Yachie, A
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Pediat, Kanazawa, Ishikawa 9208641, Japan
[2] Kanazawa Univ, Sch Med, Kanazawa, Ishikawa 9208641, Japan
[3] Shinshu Univ, Grad Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan
[4] Gunma Prefectural Inst Publ Hlth & Environm Sci, Maebashi, Gumma, Japan
[5] Gunma Childrens Med Ctr, Maebashi, Gumma, Japan
[6] Kanazawa Univ, Fac Med, Sch Hlth Sci, Dept Lab Sci, Kanazawa, Ishikawa 920, Japan
关键词
D O I
10.1182/blood-2005-03-0936
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Omenn syndrome (OS) is a rare primary immunodeficiency characterized by the presence of activated/oligoclonal T cells, eosinophilia, and the absence of circulating B cells. OS patients carry leaky mutations of recombination activating genes (RAG1 or RAG2) resulting in partial V(D)J recombination activity, whereas null mutations cause severe combined immunodeficiency with absence of mature T and B cells (T-B- SCID). Here we describe somatic mosaicism due to multiple second-site mutations in a patient with RAG1 deficiency. We found that he is homozygous for a single base deletion in the RAG1 gene, which results in frameshift and likely abrogates the protein function. However, the patient showed typical OS features. Molecular analysis revealed that several second-site mutations, all of which restored the RAG1 reading frame and resulted in missense mutations, were demonstrated in his T cells. These findings suggest that his revertant T-cell mosaicism is responsible for OS phenotype switched from T-B- SCID.
引用
收藏
页码:2099 / 2101
页数:3
相关论文
共 18 条
[1]   Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome [J].
Corneo, B ;
Moshous, D ;
Güngör, T ;
Wulffraat, N ;
Philippet, P ;
Le Deist, F ;
Fischer, A ;
de Villartay, JP .
BLOOD, 2001, 97 (09) :2772-2776
[2]  
Diamond RA, 1997, J IMMUNOL, V158, P4052
[3]   Somatic gene mutation and human disease other than cancer [J].
Erickson, RP .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2003, 543 (02) :125-136
[4]   In vivo reversion to normal of inherited mutations in humans [J].
Hirschhorn, R .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (10) :721-728
[5]   Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency [J].
Hirschhorn, R ;
Yang, DRX ;
Puck, JM ;
Huie, ML ;
Jiang, CK ;
Kurlandsky, LE .
NATURE GENETICS, 1996, 13 (03) :290-295
[6]   Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages [J].
Konno, A ;
Wada, T ;
Schurman, SH ;
Garabedian, EK ;
Kirby, M ;
Anderson, SM ;
Candotti, F .
BLOOD, 2004, 103 (02) :676-678
[7]   CD8αα memory effector T cells descend directly from clonally expanded CD8α+βhigh TCRαβ T cells in vivo [J].
Konno, A ;
Okada, K ;
Mizuno, K ;
Nishida, M ;
Nagaoki, S ;
Toma, T ;
Uehara, T ;
Ohta, K ;
Kasahara, Y ;
Seki, H ;
Yachie, A ;
Koizumi, S .
BLOOD, 2002, 100 (12) :4090-4097
[8]   Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T Cells with killer/effector phenotypes in juvenile dermatomyositis syndrome [J].
Mizuno, K ;
Yachie, A ;
Nagaoki, S ;
Wada, H ;
Okada, K ;
Kawachi, M ;
Toma, T ;
Konno, A ;
Ohta, K ;
Kasahara, Y ;
Koizumi, S .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 137 (01) :187-194
[9]   RAG-1-DEFICIENT MICE HAVE NO MATURE LYMPHOCYTES-B AND LYMPHOCYTES-T [J].
MOMBAERTS, P ;
IACOMINI, J ;
JOHNSON, RS ;
HERRUP, K ;
TONEGAWA, S ;
PAPAIOANNOU, VE .
CELL, 1992, 68 (05) :869-877
[10]   COMBINED IMMUNODEFICIENCY AND RETICULOENDOTHELIOSIS WITH EOSINOPHILIA [J].
OCHS, HD ;
DAVIS, SD ;
MICKELSON, E ;
LERNER, KG ;
WEDGWOOD, RJ .
JOURNAL OF PEDIATRICS, 1974, 85 (04) :463-465